From Trapelo Health
This white paper from Trapelo Health discusses the lack of standardization and barriers to collaboration between oncologists, payors, and genomic testing labs that have been slowing the use of precision medicine in cancer and describes how the Trapelo technology platform is delivering near real-time, evidence-based reimbursement guidance to health plans to streamline the prior authorization process and speed care for cancer patients.
Offered Free by: Trapelo Health
See All Resources from: Trapelo Health